{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:45:44Z","timestamp":1771476344132,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.annder.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T18:03:35Z","timestamp":1571767415000},"page":"36-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u00c9volution fatale du syndrome de Netherthon due \u00e0 une utilisation excessive de dermocortico\u00efdes chez un adulte"],"prefix":"10.1016","volume":"147","author":[{"given":"C.","family":"Valette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ofaiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Severino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mazereeuw-Hautier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2019.09.003_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/75977","article-title":"Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome","volume":"25","author":"Chavanas","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.annder.2019.09.003_bib0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1515\/hsz-2014-0137","article-title":"Netherton syndrome: defective kallikrein inhibition in the skin leads to skin inflammation and allergy","volume":"395","author":"Furio","year":"2014","journal-title":"Biol Chem"},{"key":"10.1016\/j.annder.2019.09.003_bib0015","first-page":"274","article-title":"Cushing's syndrome after topical application of corticosteroids","volume":"136","author":"Ruiz-Maldonado","year":"1982","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.annder.2019.09.003_bib0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.0736-8046.2004.21508.x","article-title":"An infantile Cushing's syndrome due to misused of topical steroid","volume":"21","author":"Siklar","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2019.09.003_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpag.2018.09.004","article-title":"Cushing Syndrome Induced by Topical Corticosteroids for the Treatment of Lichen Sclerosus","volume":"32","author":"Notay","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.annder.2019.09.003_bib0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/pde.13033","article-title":"Cushing's Syndrome Induced by High-Potency Topical Corticosteroids in Two Children with Palmoplantar Psoriasis Taking Acitretin","volume":"34","author":"Mah\u00e9","year":"2017","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2019.09.003_bib0035","first-page":"821","article-title":"The dermocorticoids, irreplaceable and feared","volume":"10","author":"Zenklusen","year":"2014","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.annder.2019.09.003_bib0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2019.09.003_bib0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/bjd.17203","article-title":"Management of congenital ichthyoses: European guidelines of care: Part one","volume":"180","author":"Mazereeuw-Hautier","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2019.09.003_bib0050","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/bjd.16882","article-title":"Management of congenital ichthyoses: European guidelines of care: Part Two","volume":"180","author":"Mazereeuw-Hautier","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2019.09.003_bib0055","first-page":"42","article-title":"Significant absorption of topical tacrolimus in 3\u00a0patients with Netherton syndrome","volume":"12","author":"Allen","year":"2018","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/j.annder.2019.09.003_bib0060","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/archderm.142.10.1362","article-title":"Low but detectable serum levels of tacrolimus seen with the use of very dilute, extemporaneously compounded formulations of tacrolimus ointment in the treatment of patients with Netherton syndrome","volume":"142","author":"Shah","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2019.09.003_bib0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2340\/00015555-1558","article-title":"Netherton syndrome with multiple nonmelanoma skin cancers","volume":"93","author":"van der Voort","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2019.09.003_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000245696","article-title":"Failure of cyclosporine in Netherton's syndrome","volume":"195","author":"Braun","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2019.09.003_bib0075","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jdcr.2017.07.019","article-title":"Infliximab therapy for Netherton syndrome: a case report","volume":"3","author":"Roda","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2019.09.003_bib0080","doi-asserted-by":"crossref","first-page":"i262","DOI":"10.1136\/bmj.i262","article-title":"Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden","volume":"352","author":"Raaschou","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2019.09.003_bib0085","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1136\/ard.2010.149419","article-title":"Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis","volume":"70","author":"Mariette","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2019.09.003_bib0090","first-page":"35","article-title":"Squamous cell carcinoma of the lip associated with adalimumab therapy for ankylosing spondylitis: a case report and review of TNF-\u03b1 inhibitors and cutaneous carcinoma risk","volume":"92","author":"Zitelli","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2019.09.003_bib0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/039463201402700213","article-title":"Carcinoma cuniculatum in course of etanercept: blocking autoimmunity but propagation of carcinogenesis?","volume":"27","author":"Tchernev","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.annder.2019.09.003_bib0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000071791","article-title":"Early development of multiple epithelial neoplasms in Netherton syndrome","volume":"207","author":"Krasagakis","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2019.09.003_bib0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/08923973.2015.1115518","article-title":"A case of Netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels","volume":"38","author":"Yalcin","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.annder.2019.09.003_bib0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s10875-011-9645-0","article-title":"Subcutaneous immunoglobulin replacement therapy with Hizentra\u00ae is safe and effective in two infants","volume":"32","author":"Gallagher","year":"2012","journal-title":"J Clin Immunol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963819303138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963819303138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:07:46Z","timestamp":1758971266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963819303138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0151963819303138"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2019.09.003","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9volution fatale du syndrome de Netherthon due \u00e0 une utilisation excessive de dermocortico\u00efdes chez un adulte","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}